animal-vaccine-development.com Open in urlscan Pro
5.134.13.35  Public Scan

Form analysis
1 forms found in the DOM

GET https://animal-vaccine-development.com/

<form role="search" method="get" id="searchform" class="searchform" action="https://animal-vaccine-development.com/">
  <div>
    <label class="screen-reader-text" for="s"> Search</label>
    <input type="text" value="" name="s" id="s" placeholder="">
    <input type="submit" id="searchsubmit" value="Search">
  </div>
</form>

Text Content

Skip to content




JUNE 26-28, 2019
BOSTON, MA

Menu

 * Home
 * About
   * About Event
   * Who Attends
   * Venue & Accommodation
   * About Microbiome Movement
   * Media Hub
 * What’s On?
   * Full Event Guide
   * Speakers
   * Pre-Conference Workshops
   * Conference Day 1
   * Conference Day 2
 * Partner
   * Why Partner?
   * Partnership Prospectus
   * 2019 Partners
 * FAQs
 * Take Part
   * Register
   * Pricing
   * Contact Us


 * Home
 * About
   * About Event
   * Who Attends
   * Venue & Accommodation
   * About Microbiome Movement
   * Media Hub
 * What’s On?
   * Full Event Guide
   * Speakers
   * Pre-Conference Workshops
   * Conference Day 1
   * Conference Day 2
 * Partner
   * Why Partner?
   * Partnership Prospectus
   * 2019 Partners
 * FAQs
 * Take Part
   * Register
   * Pricing
   * Contact Us




RETURNING FOR 4TH YEAR
JUNE 26-28, 2019
BOSTON, MA

2023 EVENT GUIDE
SECURE YOUR PLACE
PARTNER

Welcome to the 8th Oncolytic Virotherapy Summit: Engineering Oncolytic Viruses
Towards Revolutionary Anti-Cancer Immunotherapies

 

Recent years have seen highly promising and rapid advances in the pre-clinical
development and clinical evolution of oncolytic virotherapies. They are
increasingly being recognised as a therapy with huge potential to change the
landscape for cancer immunotherapy. In the past 3 months alone, we have
witnessed 20 new drugs entering into pre-clinical and clinical phases, and
exciting FDA Fast Track Designation for Candel Therapeutics OV candidate - this
community continues to maximize the impact of these hopeful therapies.


EXPERT SPEAKER FACULTY INCLUDES:




Unite with 100+ OV trailblazers across sessions spanning Early Discovery,
Translation, Clinical Development, Chemistry, Manufacturing & Controls (CMC) and
Regulations to overcome the industry's largest and critical bottlenecks. Meet
your community to hear how they address the major challenges facing the
industry:

 

Investigate the Manufacturing Challenges & Approaches to Produce a Successful
Oncolytic Virus to Ensure its Quality, Traceability, & Reliability
Understand the raw materials and supply chain management of your oncolytic virus
and, explore the importance of stability of your viral vectors with insights
from VYRIAD & Circio Bio Optimize the Immunogenicity of Your Oncolytic Virus
Candidate: Maximizing Effectiveness & Minimizing Side Effects in Cancer
Treatment
Discuss the current immunogenicity studies to support FIM studies and assess the
safety and efficacy of your oncolytic virus with insights from Boehringer
Ingelheim & Omios Biologics Review How to Bridge the Gap Between Pharma, Biotech
& Investors to Facilitate the Growth & Development of This Field
Address the importance of collaboration and investment in advancing pharma and
biotech innovations, and discuss the strategies for mitigating risks and
maximizing returns on investment with insights from Candel Therapeutics & Valo
Therapeutics  Discover the Potential of Using Combination Therapy for Improved
Therapeutic Outcomes
Investigate the innovative combinations of oncolytic viruses with other
therapeutic modalities as well as review the current pre-clinical and clinical
studies demonstrating anti-tumor efficacy with insights from Replimune & Oncolys
Explore the Latest Clinical Data & How to Design Better Clinical Trials to
Develop More Effective Oncolytic Virus's
Discussing the most up to date clinical data on advancements in oncolytic
viruses and what are the possible breakthroughs and innovations we may see in
the next year with insights from Lokon Pharma & Calidi Therapeutics




PAST ATTENDEES INCLUDE:



2023 EVENT GUIDE
BACK TO TOP


OUR CONTACT DETAILS

T:  (+1) 617 455 4188
E: info@hansonwade.com


VENUE DETAILS

Revere Hotel Boston Common
200 Stuart St
Boston
MA 02116
USA 


ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across
industries. Our primary method for achieving this is by creating exclusive
business conferences that gather together the world's smartest thinkers and
doers.


LOCATION




SEARCH

Search


ORGANISED BY



TERMS & CONDITIONS




© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade
Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.